Demonstration of the usefulness of the metabolomic approach was provided recently by Johansen et al. [41], who showed that the metabolomic profile of PD patients carrying the LRRK2 G2019S haplotype differed from that of cases with sporadic PD. The gene discussed is LRRK2; the disease is Parkinson disease.